{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:01:48Z","timestamp":1791306108039,"version":"4.3.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T00:00:00Z","timestamp":1236211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T00:00:00Z","timestamp":1236211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1038\/leu.2009.37","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T10:48:15Z","timestamp":1236250095000},"page":"900-904","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":215,"title":["Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates"],"prefix":"10.1038","volume":"23","author":[{"given":"A","family":"Tefferi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R L","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K-H","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Abdel-Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T L","family":"Lasho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C M","family":"Finke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Mullally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C-Y","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Pardanani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D G","family":"Gilliland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,5]]},"reference":[{"key":"BFleu200937_CR1","first-page":"lba-3","volume":"112","author":"F Delhommeau","year":"2008","unstructured":"Delhommeau F, Dupont S, James C, Masse A, le Couedic JP, Valle VD et al. TET2 is a novel tumor suppressor gene inactivated in myeloproliferative neoplasms: identification of a Pre-JAK2 V617F event. ASH Annual Meeting Abstracts 2008; 112: lba-3: Late-Breaking Abstract.","journal-title":"ASH Annual Meeting Abstracts"},{"key":"BFleu200937_CR2","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1038\/sj.leu.2403818","volume":"19","author":"F Viguie","year":"2005","unstructured":"Viguie F, Aboura A, Bouscary D, Ramond S, Delmer A, Tachdjian G et al. Common 4q24 deletion in four cases of hematopoietic malignancy: early stem cell involvement? Leukemia 2005; 19: 1411\u20131415.","journal-title":"Leukemia"},{"key":"BFleu200937_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/sj.leu.2404955","volume":"22","author":"A Tefferi","year":"2008","unstructured":"Tefferi A, Vardiman JW . Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2008; 22: 14\u201322.","journal-title":"Leukemia"},{"key":"BFleu200937_CR4","first-page":"1","volume-title":"World Health Organization Classification of Tumours of Hematopoietic and Lymphoid Tissues","author":"ES Jaffe","year":"2001","unstructured":"Jaffe ES, Harris NL, Stein H, Vardiman JW . World Health Organization Classification of Tumours of Hematopoietic and Lymphoid Tissues. IARC Press: Lyon, France, 2001, pp 1\u2013351."},{"key":"BFleu200937_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0165-4608(85)90032-9","volume":"18","author":"GW Dewald","year":"1985","unstructured":"Dewald GW, Broderick DJ, Tom WW, Hagstrom JE, Pierre RV . The efficacy of direct, 24-h culture, and mitotic synchronization methods for cytogenetic analysis of bone marrow in neoplastic hematologic disorders. Cancer Genet Cytogenet 1985; 18: 1\u201310.","journal-title":"Cancer Genet Cytogenet"},{"key":"BFleu200937_CR6","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0145-2126(02)00303-X","volume":"27","author":"A Pardanani","year":"2003","unstructured":"Pardanani A, Reeder TL, Kimlinger TK, Baek JY, Li CY, Butterfield JH et al. Flt-3 and c-kit mutation studies in a spectrum of chronic myeloid disorders including systemic mast cell disease. Leuk Res 2003; 27: 739\u2013742.","journal-title":"Leuk Res"},{"key":"BFleu200937_CR7","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/sj.leu.2405097","volume":"22","author":"A Tefferi","year":"2008","unstructured":"Tefferi A, Lasho TL, Huang J, Finke C, Mesa RA, Li CY et al. Low JAK2V617F allele burden in primary myelofibrosis, compared to either a higher allele burden or unmutated status, is associated with inferior overall and leukemia-free survival. Leukemia 2008; 22: 756\u2013761.","journal-title":"Leukemia"},{"key":"BFleu200937_CR8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s002770050439","volume":"77","author":"O Afonja","year":"1998","unstructured":"Afonja O, Amorosi E, Ashman L, Takeshita K . Multilineage involvement and erythropoietin-\u2018independent\u2019 erythroid progenitor cells in a patient with systemic mastocytosis. Ann Hematol 1998; 77: 183\u2013186.","journal-title":"Ann Hematol"},{"key":"BFleu200937_CR9","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1182\/blood-2005-03-1183","volume":"106","author":"DP Steensma","year":"2005","unstructured":"Steensma DP, Dewald GW, Lasho TL, Powell HL, McClure RF, Levine RL et al. The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both \u2018atypical\u2019 myeloproliferative disorders and myelodysplastic syndromes. Blood 2005; 106: 1207\u20131209.","journal-title":"Blood"},{"key":"BFleu200937_CR10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.2353\/jmoldx.2008.070061","volume":"10","author":"K Sotlar","year":"2008","unstructured":"Sotlar K, Bache A, Stellmacher F, Bultmann B, Valent P, Horny HP . Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a (corrected) clonal hematological non-mast (corrected) cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F. J Mol Diagn 2008; 10: 58\u201366.","journal-title":"J Mol Diagn"},{"key":"BFleu200937_CR11","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1182\/blood-2006-04-015545","volume":"108","author":"AC Garcia-Montero","year":"2006","unstructured":"Garcia-Montero AC, Jara-Acevedo M, Teodosio C, Sanchez ML, Nunez R, Prados A et al. KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood 2006; 108: 2366\u20132372.","journal-title":"Blood"},{"key":"BFleu200937_CR12","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.4049\/jimmunol.180.8.5466","volume":"180","author":"M Mayerhofer","year":"2008","unstructured":"Mayerhofer M, Gleixner KV, Hoelbl A, Florian S, Hoermann G, Aichberger KJ et al. Unique effects of KIT D816V in BaF3 cells: induction of cluster formation, histamine synthesis, and early mast cell differentiation antigens. J Immunol 2008; 180: 5466\u20135476.","journal-title":"J Immunol"},{"key":"BFleu200937_CR13","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1158\/1078-0432.CCR-08-0366","volume":"14","author":"S Verstovsek","year":"2008","unstructured":"Verstovsek S, Tefferi A, Cortes J, O\u2019Brien S, Garcia-Manero G, Pardanani A et al. Phase II study of dasatinib in Philadelphia chromosome-negative acute and chronic myeloid diseases, including systemic mastocytosis. Clin Cancer Res 2008; 14: 3906\u20133915.","journal-title":"Clin Cancer Res"},{"key":"BFleu200937_CR14","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1182\/blood-2005-04-1568","volume":"106","author":"J Gotlib","year":"2005","unstructured":"Gotlib J, Berube C, Growney JD, Chen CC, George TI, Williams C et al. Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation. Blood 2005; 106: 2865\u20132870.","journal-title":"Blood"},{"key":"BFleu200937_CR15","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","volume":"25","author":"P Valent","year":"2001","unstructured":"Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001; 25: 603\u2013625.","journal-title":"Leuk Res"},{"key":"BFleu200937_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1746-1596-2-37","volume":"2","author":"C Kahler","year":"2007","unstructured":"Kahler C, Didlaukat S, Feller AC, Merz H . Sensitive and reliable detection of Kit point mutation Asp 816 to Val in pathological material. Diagn Pathol 2007; 2: 37.","journal-title":"Diagn Pathol"},{"key":"BFleu200937_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/0165-4608(93)90123-4","volume":"70","author":"F Mertens","year":"1993","unstructured":"Mertens F, Johansson B, Mitelman F . Age- and gender-related heterogeneity of cancer chromosome aberrations. Cancer Genet Cytogenet 1993; 70: 6\u201311.","journal-title":"Cancer Genet Cytogenet"},{"key":"BFleu200937_CR18","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1365-2141.2005.05764.x","volume":"131","author":"AP Wolanskyj","year":"2005","unstructured":"Wolanskyj AP, Lasho TL, Schwager SM, McClure RF, Wadleigh M, Lee SJ et al. JAK2 mutation in essential thrombocythaemia: clinical associations and long-term prognostic relevance. Br J Haematol 2005; 131: 208\u2013213.","journal-title":"Br J Haematol"},{"key":"BFleu200937_CR19","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1365-2141.2005.05776.x","volume":"131","author":"A Tefferi","year":"2005","unstructured":"Tefferi A, Lasho TL, Schwager SM, Steensma DP, Mesa RA, Li CY et al. The JAK2 tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates. Br J Haematol 2005; 131: 320\u2013328.","journal-title":"Br J Haematol"},{"key":"BFleu200937_CR20","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJMoa025217","volume":"348","author":"J Cools","year":"2003","unstructured":"Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, Cortes J et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003; 348: 1201\u20131214.","journal-title":"N Engl J Med"},{"key":"BFleu200937_CR21","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1182\/blood-2004-03-0787","volume":"104","author":"A Pardanani","year":"2004","unstructured":"Pardanani A, Brockman SR, Paternoster SF, Flynn HC, Ketterling RP, Lasho TL et al. FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia. Blood 2004; 104: 3038\u20133045.","journal-title":"Blood"},{"key":"BFleu200937_CR22","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1038\/leu.2008.287","volume":"22","author":"J Gotlib","year":"2008","unstructured":"Gotlib J, Cools J . Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias. Leukemia 2008; 22: 1999\u20132010.","journal-title":"Leukemia"},{"key":"BFleu200937_CR23","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1182\/blood-2005-03-1320","volume":"106","author":"AV Jones","year":"2005","unstructured":"Jones AV, Kreil S, Zoi K, Waghorn K, Curtis C, Zhang L et al. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood 2005; 106: 2162\u20132168.","journal-title":"Blood"},{"key":"BFleu200937_CR24","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/sj.leu.2402500","volume":"16","author":"K Deguchi","year":"2002","unstructured":"Deguchi K, Gilliland DG . Cooperativity between mutations in tyrosine kinases and in hematopoietic transcription factors in AML. Leukemia 2002; 16: 740\u2013744.","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu200937.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu200937","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu200937.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T12:43:13Z","timestamp":1648730593000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu200937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["BFleu200937"],"URL":"https:\/\/doi.org\/10.1038\/leu.2009.37","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,5]]},"assertion":[{"value":"23 January 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}